Officials at the Dean Clinic and Dean Health Plan in Madison, Wis., said they donated EpiPens -- used to treat an allergic reaction -- to 243 schools. "EpiPens are a crucial tool needed to help stop an allergic reaction," Dr. Reid Olson, an allergist at the Dean Clinic, said in a statement. "EpiPens are a first line of treatment and they can actually stop a reaction in a matter of minutes." Wisconsin law allows children with known allergies to have an EpiPen with them in schools, but Olson said it is still important schools have a backup for children who get their first allergic reaction in school. "If a child's first exposure to the allergen is at school, they may not have an EpiPen or an action plan set up with the school," Olson said. "This is when having the device in the schools is critically important." The program will run through the 2016-17 school year. New EpiPens would be delivered to the schools each of the next five years. If an EpiPen is used during the school year, a new EpiPen would be replaced without cost to the school district, Olson said. "The program was piloted in the Madison School District last year when we donated more than 40 EpiPens to the district," Craig Samitt, chief executive officer of the Dean Clinic, said. "First grade Gompers Elementary School student, Talon Hogan gave us all the reason in the world to not only continue the program, but expand it, after a donated EpiPen was used on him during an allergic reaction at school."
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor